Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L O Pedersen

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cancer Letters|June 22, 1999
Human p53(264-272) HLA-A2 binding peptide is an immunodominant epitope in DNA-immunized HLA-A2 transgenic miceT R Petersen, S Bregenholta, L O Pedersen, et al.
Scandinavian Journal of Immunology|August 1, 1994
Antibodies directed against monomorphic and evolutionary conserved self epitopes may be generated in 'knock-out' mice. Development of monoclonal antibodies directed against monomorphic MHC class I determinantsM H Claesson, B Endel, J Ulrik, et al.
European Journal of Immunology|August 1, 1996
Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of bindingA Stryhn, L O Pedersen, T Romme, et al.
The Journal of Biological Chemistry|May 10, 1996
Molecular characterization of the di-leucine-based internalization motif of the T cell receptorJ Dietrich, X Hou, A M Wegener, et al.
Scandinavian Journal of Immunology|October 16, 1999
A single-chain fusion molecule consisting of peptide, major histocompatibility gene complex class I heavy chain and beta2-microglobulin can fold partially correctly, but binds peptide inefficientlyC Sylvester-Hvid, L L Nielsen, N J Hansen, et al.
Scandinavian Journal of Immunology|January 1, 1994
The interaction between beta 2-microglobulin (beta 2m) and purified class-I major histocompatibility (MHC) antigenL O Pedersen, A S Hansen, A C Olsen, et al.
Cancer Research|August 17, 2001
Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patientsM H Andersen, L O Pedersen, B Capeller, et al.
Cancer Research|February 24, 2001
Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patientsD Schrama, M H Andersen, P Terheyden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996
pH dependence of MHC class I-restricted peptide presentationA Stryhn, L O Pedersen, T Romme, et al.
European Journal of Immunology|June 1, 1995
The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2mL O Pedersen, A Stryhn, T L Holter, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Letters|June 22, 1999
Human p53(264-272) HLA-A2 binding peptide is an immunodominant epitope in DNA-immunized HLA-A2 transgenic miceT R Petersen, S Bregenholta, L O Pedersen, et al.
Scandinavian Journal of Immunology|August 1, 1994
Antibodies directed against monomorphic and evolutionary conserved self epitopes may be generated in 'knock-out' mice. Development of monoclonal antibodies directed against monomorphic MHC class I determinantsM H Claesson, B Endel, J Ulrik, et al.
European Journal of Immunology|August 1, 1996
Peptide binding specificity of major histocompatibility complex class I resolved into an array of apparently independent subspecificities: quantitation by peptide libraries and improved prediction of bindingA Stryhn, L O Pedersen, T Romme, et al.
The Journal of Biological Chemistry|May 10, 1996
Molecular characterization of the di-leucine-based internalization motif of the T cell receptorJ Dietrich, X Hou, A M Wegener, et al.
Scandinavian Journal of Immunology|October 16, 1999
A single-chain fusion molecule consisting of peptide, major histocompatibility gene complex class I heavy chain and beta2-microglobulin can fold partially correctly, but binds peptide inefficientlyC Sylvester-Hvid, L L Nielsen, N J Hansen, et al.
Scandinavian Journal of Immunology|January 1, 1994
The interaction between beta 2-microglobulin (beta 2m) and purified class-I major histocompatibility (MHC) antigenL O Pedersen, A S Hansen, A C Olsen, et al.
Cancer Research|August 17, 2001
Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patientsM H Andersen, L O Pedersen, B Capeller, et al.
Cancer Research|February 24, 2001
Oligoclonal T-cell receptor usage of melanocyte differentiation antigen-reactive T cells in stage IV melanoma patientsD Schrama, M H Andersen, P Terheyden, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 1, 1996
pH dependence of MHC class I-restricted peptide presentationA Stryhn, L O Pedersen, T Romme, et al.
European Journal of Immunology|June 1, 1995
The interaction of beta 2-microglobulin (beta 2m) with mouse class I major histocompatibility antigens and its ability to support peptide binding. A comparison of human and mouse beta 2mL O Pedersen, A Stryhn, T L Holter, et al.
Pageof 3